1. Home
  2. RHI vs PLSE Comparison

RHI vs PLSE Comparison

Compare RHI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robert Half Inc.

RHI

Robert Half Inc.

HOLD

Current Price

$37.85

Market Cap

4.5B

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

N/A

Current Price

$52.77

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RHI
PLSE
Founded
1948
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.6B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
RHI
PLSE
Price
$37.85
$52.77
Analyst Decision
Hold
Buy
Analyst Count
7
1
Target Price
$30.33
$22.00
AVG Volume (30 Days)
1.7M
578.9K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
8.68%
N/A
EPS Growth
N/A
N/A
EPS
0.40
N/A
Revenue
$5,378,506,000.00
N/A
Revenue This Year
$1.27
$840.00
Revenue Next Year
$5.95
$287.54
P/E Ratio
$94.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.83
$12.56
52 Week High
$46.70
$58.90

Technical Indicators

Market Signals
Indicator
RHI
PLSE
Relative Strength Index (RSI) 32.84 67.23
Support Level $26.19 $24.27
Resistance Level $46.36 N/A
Average True Range (ATR) 1.58 3.85
MACD -1.04 -0.21
Stochastic Oscillator 0.33 63.42

Price Performance

Historical Comparison
RHI
PLSE

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Share on Social Networks: